Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Source: SeekingAlpha
2026-05-18 11:41:00 ET
By Diederik Stadig , Senior Economist, Healthcare & Technology
Executive summary
Marty Makary, the US Food and Drug Administration (FDA) commissioner, has been ousted just over a year into the role amid criticism from both inside and outside the Trump administration over his stance on flavoured vapes and abortion pills, among others....
Read the full article on Seeking Alpha
For further details see:
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
Range Cancer Therapeutics ETF
NASDAQ: CNCR
CNCR Trading
-4.32% G/L:
$9.02 Last:
3,077 Volume:
$9.41 Open:
